Author

H.-H. Liu

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell signaling & trafficking· 2 Research Focus:cell type annotation· 2 Research Focus:differential expression· 2 Approach:experimental assay· 2 Organism:human· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

C.-Y. Chao· 2 shared G.-B. Lin· 2 shared W.-T. Chen· 2 shared Y.-M. Chen· 2 shared Y.-Y. Kuo· 2 shared S.-J. Leu· 1 shared

Activity by Year

2022-2022 · peak 2/yr

Co-Author Collaboration Network

6 top collaborators · 15 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

C.-Y. Chao

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

ImmunologybioRxivPreprintDec 20, 2022

Thermal cycling-hyperthermia down-regulates liposaccharide-induced inflammation in human blood and helps with clearance of herpes simplex virus type 1

Y.-Y. Kuo, G.-B. Lin, W.-T. Chen…·C.-Y. Chao

The paper evaluates thermal cycling-hyperthermia (TC-HT) and finds it reduces LPS-induced inflammation and enhances HSV-1 clearance by macrophages compared to standard hyperthermia.

DOI 10.1101/2022.12.20.521318

humanexperimental assay

Cancer BiologybioRxivMay 3, 2022

Thermal cycling hyperthermia sensitizes non-small cell lung cancer A549 cells to EGFR-tyrosine kinase inhibitor Erlotinib

G.-B. Lin, W.-T. Chen, Y.-Y. Kuo…·C.-Y. Chao

This study shows that thermal cycling hyperthermia enhances the effectiveness of Erlotinib in A549 NSCLC cells by reducing IC50 and inducing cell cycle arrest.

DOI 10.3892/or.2025.8891

humanexperimental assay